AUMED, a.s. received a grant for the Innovation Project entitled “TFI Transfer Factor – Medicine”

AUMED, a.s. received a grant in the Operational Program Enterprise and Innovation for Competitiveness under the Innovation Call – Innovation Project – Call VIII for a project entitled “TFI Transfer Factor – Medicine”, registration number CZ.01.1.02 / 0.0 / 0.0 / 20_318 / 0026008. The main purpose of this grant is to strengthen the company’s innovative performance and increase market competitiveness.

The aim and intention of the project is to create a new production and control center of AUMED, a.s., which will use the results of its own R&D for the production of an innovated preparation based on the transfer factor (TFI). The innovative immunomodulator will be fully competitive on the world markets.

The project is part of the long-term business concept and strategy of AUMED, a.s.. The project is focused on the production application of development results; specifically for the introduction of a new product (TFI) into standard production.